No Data
No Data
Charles River and Captain T Cell Sign Vector Production Agreement
Charles River Laboratories, Captain T Cell Enter Manufacturing Deal
Charles River Laboratories (CRL) and Captain T Cell said Monday that they have entered into a plasmid DNA and retrovirus vector production program deal. Captain T Cell will use plasmid and viral vecto
Express News | Charles River Laboratories And Captain T Cell Announce Plasmid DNA And Retrovirus Vector Production Agreement; Captain T Cell To Utilize Charles River's CGT Accelerator Program For Phase I Clinical Trial Of TCR-T Cell Therapy For Solid Tumors
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
Leveraging CGT CDMO expertise to support T-cell immunotherapy clinical trial Charles River Laboratories International, Inc. (NYSE:CRL) and Captain T Cell, a spinoff from the renowned Max Delbrück Center Berlin,
Express News | Charles River Laboratories International Inc : Baird Raises Target Price to $271 From $270
Charles River and Octaura Launch Two-Way Interface for Simplified Syndicated Loan Trading
No Data